Approvals/TGA/GANVADO denosumab (rch) 70mg/mL (120mg/1.7mL) solution for injection vial

Approved

STANDARD

GANVADO denosumab (rch) 70mg/mL (120mg/1.7mL) solution for injection vial

Amgen Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 9504cf0b563a424d
Product Name: GANVADO denosumab (rch) 70mg/mL (120mg/1.7mL) solution for injection vial
Artg Id: 461905
Artg Name: GANVADO denosumab (rch) 70mg/mL (120mg/1.7mL) solution for injection vial
Sponsor: Amgen Australia Pty Ltd
Company Detail Path: /organization/amgen-australia-pty-ltd
Artg Date: 2024-11-05
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

9504cf0b563a424d

Type

Standard